Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Trials
View this publicationTrials
View this publicationPneumo news
View this publicationJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
View this publicationFrontiers in neurology
View this publicationFrontiers in cardiovascular medicine
View this publicationFrontiers in cell and developmental biology
View this publicationEuropean journal of immunology
View this publicationHamostaseologie
View this publicationWiley interdisciplinary reviews. Cognitive science
View this publicationInternational journal of colorectal disease
View this publication